Read More Apparatus Hutchison Pharmaceuticals Announces Approval Of Cd73 Monoclonal Antibody Mupadolimab In Phase I/Ib Clinical Trial In China Nov 13, 2024
Read More Medical Neoadjuvant Chemotherapy Reduces Colon Cancer Recurrence Rate By 28%, With Fewer Post-Operative Complications, Study Shows Nov 15, 2024
Read More Medical New Research Shows Promise For Bone Marrow Transplant Recipient Patients To Reduce Treatment Side Effects! Nov 19, 2024
